Wiseman Scott, Savadelis Molly D, Maree Riaan, Momberg Mandie, Whitehead Liezl, Young Lisa
Elanco Animal Health, Bartley Way, Hook, RG27 9XA, UK.
Elanco Animal Health, Innovation Way, Greenfield, IN, 46140, USA.
Parasit Vectors. 2025 Aug 13;18(1):344. doi: 10.1186/s13071-025-06965-y.
Haemaphysalis longicornis, the longhorned tick, is an invasive tick species that has been identified in increasing numbers and regions across the USA. This tick species is a competent vector for various pathogens to dogs, humans, and other species, with heavy infestations documented to lead to exsanguination. Therefore, determination of ectoparasiticides providing adequate treatment and control of H. longicornis is imperative to help reduce vector-borne disease transmission and protect against infestation in dogs.
Three laboratory studies were conducted to evaluate the efficacy of Credelio Quattro and Credelio for the treatment and control of H. longicornis. A total of 30 dogs per study were randomized to receive either placebo, Credelio Quattro, or Credelio on Day 0 according to a complete block design on the basis of pre-treatment live attached H. longicornis counts, infested on Day -7. To assess efficacy against preexisting infestations, enrolled dogs were infested with 50 unfed adult H. longicornis on Day -2 or -1 prior to treatment. Residual efficacy post-treatment was evaluated with subsequent infestations on Days 5, 12, 19, and 30. All ticks were collected and evaluated as live or dead and free or attached 48 h after treatment or infestation.
Adequacy of infestation was achieved in at least two studies for every infestation time point evaluated. Both Credelio Quattro and Credelio provided 100% efficacy against H. longicornis from Day 2 through Day 32, with no live ticks observed on any dogs. A statistically significant number of dead ticks were recovered from both treated groups as compared with control on all assessment days. Post-treatment, treatment-related diarrhea was reported in six dogs receiving Credelio Quattro and one dog receiving Credelio on Day 0, with all dogs recovering on Day 1.
The laboratory studies described confirm the safety and effectiveness of a single dose of Credelio Quattro and Credelio, at the minimum effective dosage of 20 mg/kg lotilaner, 0.02 mg/kg moxidectin, 5 mg/kg praziquantel, 5 mg/kg pyrantel, and 20 mg/kg lotilaner, respectively, for the treatment and control of H. longicornis infestations in dogs for one month.
长角血蜱是一种入侵性蜱虫物种,在美国越来越多的地区被发现,数量也在不断增加。这种蜱虫是多种病原体传播给犬类、人类和其他物种的有效媒介,有记录显示重度感染会导致动物失血过多。因此,确定能有效治疗和控制长角血蜱的杀外寄生虫剂对于减少媒介传播疾病的传播以及预防犬类感染至关重要。
进行了三项实验室研究,以评估可立奥四联(Credelio Quattro)和可立奥(Credelio)对长角血蜱的治疗和控制效果。每项研究共有30只犬,根据预处理时附着的活的长角血蜱数量,按照完全区组设计在第0天随机接受安慰剂、可立奥四联或可立奥治疗,这些犬在第 -7天感染蜱虫。为评估对既有感染的疗效,在治疗前第 -2天或 -1天给入组犬接种50只未进食的成年长角血蜱。治疗后的残留疗效通过在第5、12、19和30天的后续感染进行评估。在治疗或感染后48小时收集所有蜱虫,并评估其存活或死亡、游离或附着状态。
在评估的每个感染时间点,至少两项研究实现了充分感染。可立奥四联和可立奥从第2天到第32天对长角血蜱的疗效均达100%,所有犬只均未观察到存活蜱虫。在所有评估日,与对照组相比,两个治疗组均回收了数量具有统计学意义的死亡蜱虫。治疗后,在第0天接受可立奥四联治疗的6只犬和接受可立奥治疗的1只犬报告了与治疗相关的腹泻,所有犬均在第1天康复。
所述实验室研究证实了单剂量可立奥四联和可立奥在最低有效剂量(分别为20mg/kg氯虫苯甲酰胺、0.02mg/kg莫昔克丁、5mg/kg吡喹酮、5mg/kg噻嘧啶和20mg/kg氯虫苯甲酰胺)下对犬类长角血蜱感染进行治疗和控制达一个月的安全性和有效性。